福安藥業(300194.SZ):第一期員工持股計劃擬減持不超2091.56萬股
格隆匯11月20日丨福安藥業(300194.SZ)公佈,公司第一期員工持股計劃所持公司股票於2019年11月19日鎖定期滿。2018年11月21日,此次協議轉讓的過户登記手續全部完成,員工持股計劃完成股票購買。公司控股股東汪天祥向公司第一期員工持股計劃轉讓股份8040萬股,佔公司總股本的6.7579%。過户日期為2018年11月20日,鎖定期為12個月。
公司第一期員工持股計劃所持股份鎖定期於2019年11月19日屆滿,根據《第一期員工持股計劃(草案)》,在鎖定期屆滿後的存續期內,管理委員會陸續變現員工持股計劃資產,並按持有人所持份額的比例,分配給持有人。現將公司第一期員工持股計劃減持計劃披露如下:此次擬減持不超過約2091.56萬股,佔公司總股本的1.7580%;減持期間:自減持計劃公告之日起15個交易日後的三個月內(即從2019年12月12日起至2020年3月11日止);減持方式:大宗交易、集中競價交易;減持價格區間:根據市場價格確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.